NorthWest Biotherapeutics Inc (NWBO)

[DocLee]

Hi, Chiugray. Like you and iwasadiver I have little doubt that theoretically the DCvax family could be modified to seek out and eliminate virus infections, but I'm not sure about the practicalities involved. From the quote you give it looks like you and iwasadiver also recognise that its use would be for if a viral infection had become chronically embedded rather than for use in the acute phase of a viraemia. This would entirely relate to the length of time that the process of dendrocyte production in vivo takes meaning that by the time the "therapeutic vaccine" had been produced for the patient's specific viral infection the vast majority of virus infections would have resolved due to the body's immune response. Consequently, one can see that only chronic viral infections which don't respond to simpler treatments would be the scenario for DCVax.